Psigryph's nanopect system for enhanced bioavailability

Overview

Psigryph Inc. is a pioneer in plant-derived nanotechnologies, creating advanced nanostructures that significantly enhance the delivery and bioavailability of nutrients, drugs, and other biologically important molecules. Unlike traditional chemically engineered nanomaterials, Psigryph's Nanopect system uses natural, non-toxic, and biodegradable substances, making it a safer alternative for applications in pharmaceuticals, health supplements, and agriculture. The system's high efficiency in intracellular delivery allows for reduced dosages and improved outcomes, as evidenced by laboratory studies involving mice.

Technical specifications

Key features:

• Utilizes plant-derived nanostructures for safe and effective delivery
• Natural, non-toxic, and biodegradable materials
• Proven to enhance bioavailability and reduce necessary dosages
• Applicable in health supplements, pharmaceuticals, food ingredients, and agriculture
• Ongoing development of spray and freeze-dried formulations to ensure stability and meet daily nutrient intake requirements

Research and development:

• Laboratory studies have shown positive effects on cholesterol, weight, and triglyceride levels in mice
• Future validations include assessments of encapsulation efficiency, stability, and bioavailability using advanced analytical techniques

Technology readiness level

The Nanopect system has reached Technology Readiness Level 9, indicating it is fully developed and ready for commercial deployment. Further studies are planned to optimize formulation stability and bioavailability, with a focus on collaborative partnerships and funding support for continued innovation.